Broad endorsement for insurance-covered blood-based CRC screening (92%) suggests payer policy could materially influence ...
Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
With the approval of anti-amyloid monoclonal antibodies to treat early-stage Alzheimer’s disease (AD), the need for accurate and early diagnosis is crucial. Blood-based biomarkers offer a promising ...
A recent study shows that accessible blood tests can accurately identify Alzheimer’s disease. When combined with standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results